Nature Search

In situ electrical resistivity and bulk porosity of the oceanic crust Costa Rica Rift

Keir Becker
R. P. Von Herzen
R. L. Newmark
Research16 Dec 1982
Nature

Volume: 300, P: 594-598
DSDP Hole 504B, the first reference section over 1 km through Layer 2 of the oceanic crust

R. N. Anderson
J. Honnorez
R. L. Newmark
Research16 Dec 1982
Nature

Volume: 300, P: 589-594
Mental illness and COVID-19 vaccination: a multinational investigation of observational & register-based data

Monitoring COVID-19 vaccine uptake in those at risk of severe disease, such as people with mental illness, is important. Here, the authors use cohort and/or health registry data from five countries in northern Europe and investigate vaccine uptake by mental illness and treatment status.

Mary M. Barker
Kadri Kõiv
Fang Fang
ResearchOpen Access26 Sept 2024
Nature Communications

Volume: 15, P: 1-13
Around Ollerton

F. M. TAYLOR
Books & Arts23 Mar 1968
Nature

Volume: 217, P: 1189
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

Sheng Xiao
Srinivasa R. Nalabolu
Jonathan A. Fletcher
Research01 Jan 1998
Nature Genetics

Volume: 18, P: 84-87
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

In a pivotal phase 2 trial, elranatamab, a bispecific antibody targeting B-cell maturation antigen (BCMA) and CD3, had a confirmed objective response rate of 61% in patients with relapsed or refractory multiple myeloma who had not previously received BCMA-directed therapy.

Alexander M. Lesokhin
Michael H. Tomasson
Mohamad Mohty
ResearchOpen Access15 Aug 2023
Nature Medicine

Volume: 29, P: 2259-2267
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

In the first-in-human trial of elranatamab, patients with refractory or relapsed multiple myeloma who received the bispecific antibody against BCMA and CD3 experienced no dose-limiting toxicities during dose escalation, and the agent showed promising clinical efficacy.

Nizar J. Bahlis
Caitlin L. Costello
Alexander M. Lesokhin
ResearchOpen Access02 Oct 2023
Nature Medicine

Volume: 29, P: 2570-2576
Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL gene

SP Romana
H Poirel
OA Bernard
Research03 Nov 1999
Leukemia

Volume: 13, P: 1754-1759
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

A Vazina
J Baniel
E Friedman
ResearchOpen Access25 Jul 2000
British Journal of Cancer

Volume: 83, P: 463-466
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

Matthew Walter and colleagues report the whole-genome sequencing of a secondary acute myeloid leukemia sample and a matched normal tissue sample. Further analysis of additional subjects identified recurrent mutations in U2AF1 in 13/150 (8.7%) individuals with myelodysplastic syndrome.

Timothy A Graubert
Dong Shen
Matthew J Walter
Research11 Dec 2011
Nature Genetics

Volume: 44, P: 53-57
POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature

J M Fortier
J E Payton
T A Graubert
Research08 Apr 2010
Leukemia

Volume: 24, P: 950-957
Tel induces a G1 arrest and suppresses Ras-induced transformation

L Van Rompaey
M Potter
G Grosveld
Research02 Nov 2000
Oncogene

Volume: 19, P: 5244-5250
Therapeutic advances of targeting receptor tyrosine kinases in cancer

Ciprian Tomuleasa
Adrian-Bogdan Tigu
Carlo M. Croce
ReviewsOpen Access14 Aug 2024
Signal Transduction and Targeted Therapy

Volume: 9, P: 1-51
Oncogenic activation of the PDGF β receptor by the transmembrane domain of p185^neu*

Lisa M Petti
Pablo M Irusta
Daniel DiMaio
Research03 Mar 1998
Oncogene

Volume: 16, P: 843-851
Regular use of analgesics is a risk factor for renal cell carcinoma

M Gago-Dominguez
J-M Yuan
M C Yu
ResearchOpen Access10 Sept 1999
British Journal of Cancer

Volume: 81, P: 542-548
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study

G L Uy
S D Goyal
R Vij
Research24 Nov 2008
Bone Marrow Transplantation

Volume: 43, P: 793-800
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes

J D Hidalgo
R Krone
H Khoury
Research19 Jul 2004
Bone Marrow Transplantation

Volume: 34, P: 615-619
Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells

D H Spencer
M A Young
T J Ley
Research20 Jan 2015
Leukemia

Volume: 29, P: 1279-1289
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects

M A Hurchla
A Garcia-Gomez
K N Weilbaecher
Research05 Jul 2012
Leukemia

Volume: 27, P: 430-440
NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma

M Hao
R Franqui-Machin
F Zhan
CorrespondenceOpen Access12 Apr 2017
Leukemia

Volume: 31, P: 1648-1650
Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids

I Gunnarsdottir
H Tomasson
I Thorsdottir
Research20 May 2008
International Journal of Obesity

Volume: 32, P: 1105-1112
Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content

I Thorsdottir
H Tomasson
J A Martinéz
Research15 May 2007
International Journal of Obesity

Volume: 31, P: 1560-1566
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

S M Devine
R A Brown
J F DiPersio
Research18 Jul 2005
Bone Marrow Transplantation

Volume: 36, P: 531-538
The skinny on obesity and plasma cell myeloma: a review of the literature

K R Carson
M L Bates
M H Tomasson
Reviews12 May 2014
Bone Marrow Transplantation

Volume: 49, P: 1009-1015
Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

T Sato
S Goyama
M Kurokawa
ResearchOpen Access21 Apr 2014
Oncogene

Volume: 33, P: 5028-5038

Search

In situ electrical resistivity and bulk porosity of the oceanic crust Costa Rica Rift

DSDP Hole 504B, the first reference section over 1 km through Layer 2 of the oceanic crust

Mental illness and COVID-19 vaccination: a multinational investigation of observational & register-based data

Around Ollerton

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial

Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL gene

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature

Tel induces a G1 arrest and suppresses Ras-induced transformation

Therapeutic advances of targeting receptor tyrosine kinases in cancer

Oncogenic activation of the PDGF β receptor by the transmembrane domain of p185^neu*

Regular use of analgesics is a risk factor for renal cell carcinoma

Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study

Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes

Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma

Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids

Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content

Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

The skinny on obesity and plasma cell myeloma: a review of the literature

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Search

Quick links

Search

Filter By:

Search

Quick links